Apoorva Tewari Ramaswamy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Apoorva Tewari Ramaswamy has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Akhil Katragadda
College of Medicine The Ohio State University Columbus Ohio USA
2 shared publications Anees B. Chagpar
Department of Psychiatry, Yale University School of Medicine;, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut
2 shared publicationsJack Birkenbeuel
Department of Otolaryngology–Head and Neck Surgery The Ohio State University Wexner Medical Center Columbus Ohio USA
2 shared publications- Molly O. Meeker
The Ohio State University College of Medicine Columbus Ohio USA
2 shared publications Songzhu Zhao
Department of Otolaryngology–Head and Neck Surgery The Ohio State University Wexner Medical Center Columbus Ohio USA
2 shared publicationsZachary Wykoff
College of Medicine The Ohio State University Columbus Ohio USA
2 shared publications
Latest Publications
- 25 August 2026
- Published by Elsevier in Oral Oncology
- Vol. 181
Radiation-associated dysphagia in head and neck cancer: A narrative review of surgical management, diagnosis, and emerging directions
- 25 August 2026
- Published by Elsevier in Oral Oncology
- Vol. 181
Radiation-associated dysphagia in head and neck cancer: A narrative review of surgical management, diagnosis, and emerging directions
- Open Access
- 8 May 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (3)
Demographic Factors in Pharyngoesophageal Segment Size: A Scoping Review
Objective: The Pharyngoesophageal Segment (PES) is situated at the junction of the pharynx and esophagus, regulating the passage of bolus from the pharynx into the esophagus during swallowing and preventing aspiration into the airway. Decreased opening of this sphincter can result in significant swallow impairment. Knowledge of normal PES size can be critical for diagnostic purposes and treatment planning. This systematic review seeks to aggregate the evidence correlating PES size with demographic factors, including age, sex, and obesity status. Data Sources: A search performed on PubMed, Embase, Cochrane, and Ovid included literature published before August 18, 2025. Review Methods: Inclusion criteria were healthy adult populations (including cadavers). Publications investigating only animal, pediatric, or pathologic populations or that did not include demographic comparisons were excluded. Results: A total of 5815 studies were retrieved, and 679 subjects across 10 studies met the inclusion criteria. Diverse parameters were measured, including PES area, diameter, lateral diameter, and anterior–posterior diameter. With varying parameters, different bolus sizes, and few papers, conclusive findings on PES size were not found. Studies that reported the mean size for each demographic group recorded a greater male PES size than female. The data conflicted regarding a greater PES size in elderly or non‐elderly populations. Mean data regarding obesity and height were not reported but were noted not to significantly impact PES size. Conclusion: Many research gaps exist in defining normal PES size. Further research is needed to better elucidate issues like age‐related differences, as well as measurement parameters and techniques.
- 8 May 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (3)
Open AccessDemographic Factors in Pharyngoesophageal Segment Size: A Scoping Review
Objective: The Pharyngoesophageal Segment (PES) is situated at the junction of the pharynx and esophagus, regulating the passage of bolus from the pharynx into the esophagus during swallowing and preventing aspiration into the airway. Decreased opening of this sphincter can result in significant swallow impairment. Knowledge of normal PES size can be critical for diagnostic purposes and treatment planning. This systematic review seeks to aggregate the evidence correlating PES size with demographic factors, including age, sex, and obesity status. Data Sources: A search performed on PubMed, Embase, Cochrane, and Ovid included literature published before August 18, 2025. Review Methods: Inclusion criteria were healthy adult populations (including cadavers). Publications investigating only animal, pediatric, or pathologic populations or that did not include demographic comparisons were excluded. Results: A total of 5815 studies were retrieved, and 679 subjects across 10 studies met the inclusion criteria. Diverse parameters were measured, including PES area, diameter, lateral diameter, and anterior–posterior diameter. With varying parameters, different bolus sizes, and few papers, conclusive findings on PES size were not found. Studies that reported the mean size for each demographic group recorded a greater male PES size than female. The data conflicted regarding a greater PES size in elderly or non‐elderly populations. Mean data regarding obesity and height were not reported but were noted not to significantly impact PES size. Conclusion: Many research gaps exist in defining normal PES size. Further research is needed to better elucidate issues like age‐related differences, as well as measurement parameters and techniques.
- Open Access
Comparison of Esophageal Dysmotility Diagnostic Studies in Head and Neck Cancer Survivors With Dysphagia
Objective: This study aims to characterize the relationship of esophageal dysmotility on modified barium swallow (MBS) and esophagram studies with high‐resolution manometry (HRM), the gold standard of esophageal dysmotility diagnosis, in head and neck cancer (HNC) survivors with dysphagia.Study Design: Retrospective diagnostic accuracy study.Setting: Specialty dysphagia clinic at a tertiary care center.Methods: A retrospective analysis of 30 patients treated for dysphagia between 2020 and 2023 was conducted. Inclusion criteria required HNC survivors aged 18 years or older who were diagnosed with dysphagia, treated in a HNC dysphagia clinic, and completed at least one HRM study. Data were collected on patient demographics, cancer history, MBS, esophagram, and HRM studies. MBS and esophagram results were reviewed for evidence of esophageal dysmotility. HRM studies were assessed with the Chicago Classification Version 4.0. Data were summarized and analyzed using t test for continuous variables and a chi‐square test for categorical variables. McNemar's test and diagnostic odds ratios were calculated to compare diagnostic test results.Results: Of the 30 patients reviewed, 20 (67%) showed dysmotility on HRM, 15 (50.0%) completed MBS only, 2 (6.7%) completed esophagram only, and 13 (43.3%) completed both MBS and esophagram. MBS and esophagram accurately identified dysmotility in 66.7% and 76.9% of patients with confirmed dysmotility on HRM, respectively.Conclusion: Esophageal dysmotility is an understudied comorbidity of dysphagia in the HNC survivor population. Our study suggests that MBS and esophagram have limited predictive value in the assessment of dysmotility in HNC survivors with dysphagia. Thus, future studies should aim to better understand the relationship between other aspects of post‐HNC dysphagia and esophageal dysmotility.
Open AccessComparison of Esophageal Dysmotility Diagnostic Studies in Head and Neck Cancer Survivors With Dysphagia
Objective: This study aims to characterize the relationship of esophageal dysmotility on modified barium swallow (MBS) and esophagram studies with high‐resolution manometry (HRM), the gold standard of esophageal dysmotility diagnosis, in head and neck cancer (HNC) survivors with dysphagia.Study Design: Retrospective diagnostic accuracy study.Setting: Specialty dysphagia clinic at a tertiary care center.Methods: A retrospective analysis of 30 patients treated for dysphagia between 2020 and 2023 was conducted. Inclusion criteria required HNC survivors aged 18 years or older who were diagnosed with dysphagia, treated in a HNC dysphagia clinic, and completed at least one HRM study. Data were collected on patient demographics, cancer history, MBS, esophagram, and HRM studies. MBS and esophagram results were reviewed for evidence of esophageal dysmotility. HRM studies were assessed with the Chicago Classification Version 4.0. Data were summarized and analyzed using t test for continuous variables and a chi‐square test for categorical variables. McNemar's test and diagnostic odds ratios were calculated to compare diagnostic test results.Results: Of the 30 patients reviewed, 20 (67%) showed dysmotility on HRM, 15 (50.0%) completed MBS only, 2 (6.7%) completed esophagram only, and 13 (43.3%) completed both MBS and esophagram. MBS and esophagram accurately identified dysmotility in 66.7% and 76.9% of patients with confirmed dysmotility on HRM, respectively.Conclusion: Esophageal dysmotility is an understudied comorbidity of dysphagia in the HNC survivor population. Our study suggests that MBS and esophagram have limited predictive value in the assessment of dysmotility in HNC survivors with dysphagia. Thus, future studies should aim to better understand the relationship between other aspects of post‐HNC dysphagia and esophageal dysmotility.
- Open Access
Smell and Taste Impairments in Head and Neck Cancer Patients—A Scoping Review
Head and neck cancer affects millions worldwide. The risk factors are numerous, including smoking, alcohol consumption, and human papillomavirus to name a few. While improved preventative, diagnostic, and treatment methods have decreased mortality rates, the treatments (chemotherapy, radiotherapy, or surgery) often result in smell and/or taste impairments. These can impact quality of life during and after cancer treatment. A scoping review was performed to understand current research and future directions regarding smell and taste impairments in head and neck cancer patients. PRISMA guidelines were followed and Rayyan.ai was used to search and compile journal articles. Three databases, EBSCOhost, Google Scholar, and PubMed, were also searched. Search terms included smell, taste, dysgeusia, ageusia, hypogeusia, parosmia, anosmia, hyposmia, dysosmia, and head and neck cancer. A total of 1580 articles were found through Rayyan.ai and 8022 were found through the three databases, which were manually screened. Articles assessing patients with a different malignancy, benign tumors, pediatric populations, animal studies, abstracts, and review articles were excluded. A total of 47 articles were found using this strategy. Of those we identified, 37 articles discussed taste impairments, 12 articles discussed smell impairments, and 3 articles discussed treatments for smell and/or taste impairments. All 37 articles concluded that there was some taste alteration in head and neck cancer patients due to their treatment. However, the specific taste qualities (sweet, sour, salty, or bitter) that were impaired, whether taste function returned to baseline, and which treatments led to impairments varied. For the 12 studies that assessed smell impairments, the results also varied. Some studies found significant objective impairments in smell while others found no significant impairment. Zinc sulfate was not found to be an effective treatment option for taste impairments; however, a liposomal spray showed some potential. Future studies should aim to understand which treatments and types of head and neck cancer lead to chemosensory impairments, whether chemosensory alterations negatively impact a patient’s nutritional status, and treatments or preventative measures for smell and taste changes.
Open AccessSmell and Taste Impairments in Head and Neck Cancer Patients—A Scoping Review
Head and neck cancer affects millions worldwide. The risk factors are numerous, including smoking, alcohol consumption, and human papillomavirus to name a few. While improved preventative, diagnostic, and treatment methods have decreased mortality rates, the treatments (chemotherapy, radiotherapy, or surgery) often result in smell and/or taste impairments. These can impact quality of life during and after cancer treatment. A scoping review was performed to understand current research and future directions regarding smell and taste impairments in head and neck cancer patients. PRISMA guidelines were followed and Rayyan.ai was used to search and compile journal articles. Three databases, EBSCOhost, Google Scholar, and PubMed, were also searched. Search terms included smell, taste, dysgeusia, ageusia, hypogeusia, parosmia, anosmia, hyposmia, dysosmia, and head and neck cancer. A total of 1580 articles were found through Rayyan.ai and 8022 were found through the three databases, which were manually screened. Articles assessing patients with a different malignancy, benign tumors, pediatric populations, animal studies, abstracts, and review articles were excluded. A total of 47 articles were found using this strategy. Of those we identified, 37 articles discussed taste impairments, 12 articles discussed smell impairments, and 3 articles discussed treatments for smell and/or taste impairments. All 37 articles concluded that there was some taste alteration in head and neck cancer patients due to their treatment. However, the specific taste qualities (sweet, sour, salty, or bitter) that were impaired, whether taste function returned to baseline, and which treatments led to impairments varied. For the 12 studies that assessed smell impairments, the results also varied. Some studies found significant objective impairments in smell while others found no significant impairment. Zinc sulfate was not found to be an effective treatment option for taste impairments; however, a liposomal spray showed some potential. Future studies should aim to understand which treatments and types of head and neck cancer lead to chemosensory impairments, whether chemosensory alterations negatively impact a patient’s nutritional status, and treatments or preventative measures for smell and taste changes.
- 16 February 2025
- Published by Elsevier in Oral Oncology
- Vol. 162, 107219
Dysphagia in head and neck cancer patients with evidence of esophageal dysmotility on manometry
- 16 February 2025
- Published by Elsevier in Oral Oncology
- Vol. 162, 107219
Dysphagia in head and neck cancer patients with evidence of esophageal dysmotility on manometry
- 15 January 2021
- Published by Springer Nature in Dysphagia
- Vol. 37 (1) , 4-10
Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry
Weak or absent peristalsis of the esophageal musculature is a common finding in ambulatory patients suffering from dysphagia and frequently associated with gastroesophageal reflux. There is currently no pharmacologic intervention that reliably improves esophageal contractility in patients suffering from various esophageal motility disorders. Our objective was to evaluate the acute effects of pyridostigmine on high-resolution manometry parameters in patients suffering from dysphagia with evidence of esophageal dysmotility. Pyridostigmine is an acetylcholinesterase inhibitor which increases effective concentrations of acetylcholine at the neuromuscular junction of both striated and smooth muscle cells. We conducted a prospective crossover study of five patients with dysphagia and proven esophageal dysmotility. Three patients had baseline ineffective esophageal motility and two had achalasia. Patients underwent pharyngeal and esophageal manometry before and after pyridostigmine administration. The median distal contractile integral (DCI), a marker of esophageal contractile vigor, was significantly higher post pyridostigmine administration 3001 (1950.3–3703.2) mmHg × s × cm compared to pre-pyridostigmine DCI of 1229.9 (956.2–2100) mmHg × s × cm; P < 0.001. Pre-pyridostigmine 18/25 (72%) of the patient’s swallows was peristaltic compared to 25/25 (100%) post-pyridostigmine; P < 0.005. No other pharyngeal or esophageal high-resolution manometry parameter differed significantly after pyridostigmine administration. The results of this pilot study demonstrate that pyridostigmine acutely improves esophageal contractile vigor in patients suffering from dysphagia with esophageal dysmotility. Further investigation with larger sample size, longer follow-up, side effect profile, and patient-reported outcome measures is still needed to determine the clinical usefulness of pyridostigmine in specific disorders of esophageal motility.
- 15 January 2021
- Published by Springer Nature in Dysphagia
- Vol. 37 (1) , 4-10
Effects of Pyridostigmine on Esophageal and Pharyngeal Motility in Dysphagic Patients Undergoing High-Resolution Manometry
Weak or absent peristalsis of the esophageal musculature is a common finding in ambulatory patients suffering from dysphagia and frequently associated with gastroesophageal reflux. There is currently no pharmacologic intervention that reliably improves esophageal contractility in patients suffering from various esophageal motility disorders. Our objective was to evaluate the acute effects of pyridostigmine on high-resolution manometry parameters in patients suffering from dysphagia with evidence of esophageal dysmotility. Pyridostigmine is an acetylcholinesterase inhibitor which increases effective concentrations of acetylcholine at the neuromuscular junction of both striated and smooth muscle cells. We conducted a prospective crossover study of five patients with dysphagia and proven esophageal dysmotility. Three patients had baseline ineffective esophageal motility and two had achalasia. Patients underwent pharyngeal and esophageal manometry before and after pyridostigmine administration. The median distal contractile integral (DCI), a marker of esophageal contractile vigor, was significantly higher post pyridostigmine administration 3001 (1950.3–3703.2) mmHg × s × cm compared to pre-pyridostigmine DCI of 1229.9 (956.2–2100) mmHg × s × cm; P < 0.001. Pre-pyridostigmine 18/25 (72%) of the patient’s swallows was peristaltic compared to 25/25 (100%) post-pyridostigmine; P < 0.005. No other pharyngeal or esophageal high-resolution manometry parameter differed significantly after pyridostigmine administration. The results of this pilot study demonstrate that pyridostigmine acutely improves esophageal contractile vigor in patients suffering from dysphagia with esophageal dysmotility. Further investigation with larger sample size, longer follow-up, side effect profile, and patient-reported outcome measures is still needed to determine the clinical usefulness of pyridostigmine in specific disorders of esophageal motility.
- 28 December 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (9) , 2118-2120
Carcinoma presenting as idiopathic anterior glottic webs: A case series
An anterior glottic web is an abnormal fusion of the anterior aspect of the membranous vocal folds. Noncongenital glottic webs are usually iatrogenic from intubation or laryngeal surgery. We present six adult patients whose initial in‐office diagnoses were consistent with “idiopathic” benign anterior glottic webs as determined by three laryngologists (a.m.k., j.m.b., m.j.p.). Further evaluation revealed the diagnoses of laryngeal squamous cell carcinoma in all cases. The high risk of malignancy in cases of idiopathic anterior glottic web necessitates biopsy for tissue diagnosis of all such lesions.Laryngoscope, 129:2118–2120, 2019
- 28 December 2018
- Published by Wiley in The Laryngoscope
- Vol. 129 (9) , 2118-2120
Carcinoma presenting as idiopathic anterior glottic webs: A case series
An anterior glottic web is an abnormal fusion of the anterior aspect of the membranous vocal folds. Noncongenital glottic webs are usually iatrogenic from intubation or laryngeal surgery. We present six adult patients whose initial in‐office diagnoses were consistent with “idiopathic” benign anterior glottic webs as determined by three laryngologists (a.m.k., j.m.b., m.j.p.). Further evaluation revealed the diagnoses of laryngeal squamous cell carcinoma in all cases. The high risk of malignancy in cases of idiopathic anterior glottic web necessitates biopsy for tissue diagnosis of all such lesions.Laryngoscope, 129:2118–2120, 2019
- 1 April 2018
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 51 (2) , 463-474
Revision Surgery for Otosclerosis
- 1 April 2018
- Published by Elsevier in Otolaryngologic Clinics of North America
- Vol. 51 (2) , 463-474
Revision Surgery for Otosclerosis
- 7 December 2017
- Published by Wiley in The Laryngoscope
- Vol. 128 (7) , 1727-1729
A case of hypoglossal nerve stimulator‐resistant obstructive sleep apnea cured with the addition of a chin strap
A population of appropriately selected patients does not respond, or does not achieve cure, with hypoglossal nerve stimulation (HGNS). We describe the case of nonresponder whose obstructive sleep apnea (OSA) resolved with the addition of chin strap. After initial placement and titration of HGNS implant, follow‐up sleep study demonstrated persistent moderate OSA. Drug‐induced sleep endoscopy demonstrated supraglottic collapse with activate neurostimulation. With mouth closure and change of stimulation settings to unipolar from bipolar, the airway collapse and desaturations improved. The follow‐up polysomnogram with (HGNS) therapy and chin strap demonstrated resolution of sleep apnea. Laryngoscope, 128:1727–1729, 2018
- 7 December 2017
- Published by Wiley in The Laryngoscope
- Vol. 128 (7) , 1727-1729
A case of hypoglossal nerve stimulator‐resistant obstructive sleep apnea cured with the addition of a chin strap
A population of appropriately selected patients does not respond, or does not achieve cure, with hypoglossal nerve stimulation (HGNS). We describe the case of nonresponder whose obstructive sleep apnea (OSA) resolved with the addition of chin strap. After initial placement and titration of HGNS implant, follow‐up sleep study demonstrated persistent moderate OSA. Drug‐induced sleep endoscopy demonstrated supraglottic collapse with activate neurostimulation. With mouth closure and change of stimulation settings to unipolar from bipolar, the airway collapse and desaturations improved. The follow‐up polysomnogram with (HGNS) therapy and chin strap demonstrated resolution of sleep apnea. Laryngoscope, 128:1727–1729, 2018
- Open Access
- 1 November 2017
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 5, 18-20
Osteoma of the superior petrous portion of the temporal bone
- 1 November 2017
- Published by Elsevier in Otolaryngology Case Reports
- Vol. 5, 18-20
Open AccessOsteoma of the superior petrous portion of the temporal bone